EN DE
Watch BrightBid Group AB (publ) for free: we tell you when fair value or trend changes.
Data-driven stock valuation

BrightBid Group AB (publ) (PERP-B) fair value: what the stock is really worth

As of Nov 12, 2026: fair value (intrinsic value) of BrightBid Group AB (publ) stock SEK 4.93, price SEK 1.94, upside +155.0%, quality 39 out of 100. Rating: strongly undervalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare · ISIN SE0022726311

BG BrightBid Group AB (publ) logo Thin data Nov 13, 2026

BrightBid Group AB (publ)

PERP-B · ST

Cheap (61% below fair value), but weak company and falling price: meets 1 of 3 rules.

Get notified free when this changes
Fair value kr 4.93 · Strongly undervalued 
Low debt 
Revenue last quarter +121% vs. a year ago. 
Mixed Growth (revenue 5y +50.3 %/yr in SEK) 
Thin margins · 1.7% net margin (TTM) 
Mixed vs. peers (6/11) 
Quality 39/100 
Falling price (downtrend) 
Negative free cash flow 
Narrow moat 23/100
Thin data 
⚠ Dilution⚠ Thinly traded
Watch BrightBid Group AB (publ) for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 219.21 kr 0.6912 Fair Value kr 4.93 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.

How to read this chart

60‑month range kr 0.6912 – kr 219.21 · fair‑value band kr 1.46 – kr 6.42 · the kr 1.94 price screens below the kr 4.93 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.

Follow BrightBid Group AB (publ) in your weekly email

Every Wednesday you see whether BrightBid Group AB (publ) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden.

Show moreShow less

The company provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations.

The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024. Perpetua Medical AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden. Perpetua Medical AB (publ) operates as a subsidiary of Nolsterby Invest AB.

Stock analysis

BrightBid Group AB (publ) (PERP-B) currently trades at kr 1.94, while our model-based Fair Value estimate is kr 4.93, implying the stock looks roughly 61% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of kr 13.31 per share, and 11 of the 13 models we run sit above the kr 1.94 price.

Bear case: the Economic Profit group reads lowest at kr 1.73, and 2 of the 13 models stay below the price. Data coverage for this calculation is low.

Scenario range: kr 1.46 (bear) to kr 6.42 (bull), the price of kr 1.94 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

BrightBid Group AB (publ) reported revenue of 14.6M SEK in FY2025 versus 8.8M SEK in FY2021, a compound +13.4%/yr. Reported net income was 2.5M SEK in FY2025.

Key figures

Market cap 16.6M SEK (≈ $1.7M) Micro · P/E ratio 5.5 · P/S ratio 0.93 · EPS (TTM) kr 0.3500 · Net margin 16.8% · Return on equity −15.6% · Return on assets (EBIT) −63.0% (5-year average) · Operating margin −51.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (medium confidence).

What moves the price

The share trades about 65% below its 52-week high and 23% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 9% fair-value upside, at 155%, PERP-B screens cheaper than that median.

Fair Value models

Bear kr 1.46 Fair Value kr 4.93 Bull kr 6.42
Price kr 1.94 · Upside +155.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (kr 0.3040 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV kr 1.09 kr 1.23 kr 1.34 73
Owner Earnings kr 5.94 kr 11.90 kr 22.53 69
ROIC Compounder kr 1.09 kr 1.23 kr 1.34 69
All 13 models by family
DCF Models
Owner Earnings kr 5.94 kr 11.90 kr 22.53 69
Earnings-Based
Graham-Dodd kr 1.95 kr 13.59 kr 19.07 61
Lynch FV kr 7.02 kr 10.03 kr 13.04 59
PEG = 1.0 kr 7.02 kr 10.03 kr 13.04 55
EPV kr 1.09 kr 1.23 kr 1.34 73
Multiples
P/E Multiple kr 4.73 kr 6.30 kr 7.88 63
P/S Multiple kr 2.97 kr 3.96 kr 4.95 57
EV/EBIT kr 2.35 kr 3.02 kr 3.70 65
EV/EBITDA kr 4.03 kr 5.27 kr 6.50 67
EV/Revenue kr 1.77 kr 2.39 kr 3.01 53
Economic Profit
Residual Income kr 1.98 kr 2.22 kr 2.81 68
ROIC Compounder kr 1.09 kr 1.23 kr 1.34 69
Growth Earnings
Growth-Adj P/E kr 9.32 kr 13.31 kr 17.31 65

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 39/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 38
How much profit the company makes from its sales and capital
Quality Growth 80
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 50
Debt, balance sheet and risk of trouble
Investment 37
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 5
Distance to the 52-week high, does not count
New shares 50
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+109.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+50.3%
Start year 2020 (pandemic). Over 10 years: +50.6% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+38.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−763.5% (2020) → 14.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

Watch PERP-B, get fair value alerts →

Compare BrightBid Group AB (publ) with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 404 stocks

Beats the industry median on 6/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 39 · Below median
Fair Value upside +155.0% · Top 25%
Profitability
Return on assets 5.9% · Top 25%
Net margin (12 months) 2.6% · Below median
Operating margin (12 months) −51.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 120.8% · Top 25%
Balance sheet
Debt / equity 0.20× · Above median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/E (12 months) 5.5× · Cheapest 25%
P/B 0.08× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.13× · Cheapest 25%
EV/EBITDA 1.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 15
FUTURE (revenue growth)100 · sector 43
PAST (return on equity)0 · sector 0
HEALTH (low debt)90 · sector 97
DIVIDEND (yield)0 · sector 34

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥177.51 ¥202.57 +14% vs PERP-B
Boston Scientific Corporation BSX $44.20 $49.64 +12% vs PERP-B
STERIS plc STE $253.44 $281.90 +11% vs PERP-B
Stryker Corporation SYK $312.39 $343.63 +10% vs PERP-B
DexCom, Inc DXCM $81.39 $88.38 +9% vs PERP-B
GE HealthCare Technologies Inc GEHC $81.84 $69.92 −15% vs PERP-B
Edwards Lifesciences Corporation EW $105.80 $81.94 −23% vs PERP-B
Medtronic plc MDT $100.99 $74.90 −26% vs PERP-B
Abbott Laboratories, ABT $107.25 $75.28 −30% vs PERP-B
Koninklijke Philips N.V PHIA €27.26 €15.23 −44% vs PERP-B

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

BrightBid Group AB (publ): fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "BrightBid Group AB (publ) Fair Value". https://www.fairvalue-calculator.com/stock/PERP-B

Frequently asked questions

Is BrightBid Group AB (publ) (PERP-B) overvalued or undervalued?
As of Nov 13, 2026, our model estimates a fair value of kr 4.93 versus a price of kr 1.94, about +155% upside (undervalued).
What is the fair value of PERP-B?
Our model-based fair value for BrightBid Group AB (publ) is kr 4.93 (as of Nov 13, 2026), built from audited fundamentals. The current price: kr 1.94.
What is the quality score of PERP-B?
BrightBid Group AB (publ) has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for BrightBid Group AB (publ) (PERP-B)?
Our model-based price target is the fair value of kr 4.93 (as of Nov 13, 2026) from 13 valuation models. Cautious scenario kr 1.46, optimistic scenario kr 6.42. It is a calculation from audited fundamentals, not an analyst target.
What is the BrightBid Group AB (publ) stock forecast for 2026?
Our models put fair value at kr 4.93, about +155% upside versus a price of kr 1.94 (undervalued). Cautious scenario kr 1.46, optimistic scenario kr 6.42. The calculation is refreshed regularly with new filings.
What is the revenue of BrightBid Group AB (publ) (PERP-B)?
BrightBid Group AB (publ) reported trailing-twelve-month revenue of about 19.6M SEK (latest available figure, as of Nov 13, 2026).
What is the intrinsic value of BrightBid Group AB (publ) (PERP-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For BrightBid Group AB (publ) it is kr 4.93 per share (as of Nov 13, 2026), against a price of kr 1.94. It is the blended result of 13 valuation models in 5 families (DCF Models, Earnings-Based, Multiples, Economic Profit, Growth Earnings).
Is BrightBid Group AB (publ) stock overvalued or undervalued in 2026?
As of Nov 13, 2026, PERP-B trades below its calculated fair value: price kr 1.94, fair value kr 4.93, a gap of about +155% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PERP-B?
No. The price is what the market pays today (kr 1.94); the fair value is what the company's own numbers justify (kr 4.93). For BrightBid Group AB (publ) the two are kr 3.00 per share apart. That gap is exactly why we show both numbers side by side.
How much is BrightBid Group AB (publ) worth?
The market values BrightBid Group AB (publ) at about 16.6M SEK (market capitalisation, as of Nov 13, 2026). Per share that is kr 1.94; our models calculate a fair value of kr 4.93 per share.
What do the bullish and bearish scenarios say about PERP-B?
Our models span a range for BrightBid Group AB (publ): cautious scenario kr 1.46, base kr 4.93, optimistic kr 6.42 per share (as of Nov 13, 2026, price kr 1.94). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PERP-B?
BrightBid Group AB (publ) trades at a price-to-earnings ratio of 5.5 (as of Nov 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 4.93 is built from several models across several years. Other multiples: P/B 0.1, P/S 0.1, EV/EBITDA 1.0.
How solid is the balance sheet of BrightBid Group AB (publ) (PERP-B)?
Balance-sheet figures for BrightBid Group AB (publ) (as of Nov 13, 2026): return on equity −15.6%, debt of 0.20 per unit of equity. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is PERP-B from its 52-week high?
BrightBid Group AB (publ) trades at kr 1.94, about 65% below its 52-week high of kr 5.56 and 23% above the low of kr 1.58 (as of Nov 12, 2026). Distance from the high says nothing about value: that is what the fair value of kr 4.93 is for.
Which stocks are comparable to BrightBid Group AB (publ)?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is BrightBid Group AB (publ) stock attractive at the current price?
The data as of Nov 13, 2026: price kr 1.94, calculated fair value kr 4.93 (+155%), Quality Score 39/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PERP-B calculated?
We run BrightBid Group AB (publ) through 13 models from 5 families: DCF Models, Earnings-Based, Multiples, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of kr 4.93 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.3% above its aggregate fair value. BrightBid Group AB (publ) currently trades 61% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of BrightBid Group AB (publ) (PERP-B)?
The closing price on Nov 12, 2026 was kr 1.94. Our model-based fair value is kr 4.93, about +155% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with BrightBid Group AB (publ) right now?
The large discount to fair value meets weak quality (39/100). That raises the risk this is a value trap rather than a bargain. The model range is unusually wide (kr 1.46 to kr 6.42). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of BrightBid Group AB (publ)

How large is the market capitalisation of BrightBid Group AB (publ) (PERP-B)?
The market capitalisation of BrightBid Group AB (publ) is 16.6M SEK (≈ $1.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of BrightBid Group AB (publ) (PERP-B)?
The price-to-sales ratio of BrightBid Group AB (publ) is 0.93 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of BrightBid Group AB (publ) (PERP-B)?
Earnings per share at BrightBid Group AB (publ) are kr 0.3500 (price ÷ EPS = P/E 5.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of BrightBid Group AB (publ) (PERP-B)?
The net margin of BrightBid Group AB (publ) is 16.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of BrightBid Group AB (publ) (PERP-B)?
The return on equity (ROE) of BrightBid Group AB (publ) is −15.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of BrightBid Group AB (publ) (PERP-B)?
On an EBIT basis the return on assets of BrightBid Group AB (publ) is −63.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of BrightBid Group AB (publ) (PERP-B)?
The operating margin of BrightBid Group AB (publ) is −51.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at BrightBid Group AB (publ) (PERP-B)?
Revenue at BrightBid Group AB (publ) is growing +121% versus a year earlier (3y avg +12.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does BrightBid Group AB (publ) (PERP-B) generate?
The free cash flow of BrightBid Group AB (publ) is −6.5M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does BrightBid Group AB (publ) (PERP-B) hold?
BrightBid Group AB (publ) holds more cash than debt, 4.2M SEK net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch BrightBid Group AB (publ) in the live analysis

One click puts BrightBid Group AB (publ) on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.